OpenAI acquires Orchestra Bio, which builds AI agents for managing drug development, and plans to integrate its tech into OpenAI life sciences suite Rosalind (Madison Mills/Axios)

More in Technology

• TCM physician, musician, rail engineer: Three S’poreans who made a mid-career switch into tech

  ### Briefing Three Singaporeans, Soh Wen Ming, Ang Jun Jia, and Woo Jia Jian, have made mid-career switches into the tech industry, each leveraging their diverse backgrounds to excel in new roles. Soh, a former music manager, turned to software development after spotting a Step IT Up programme on LinkedIn. Ang, a TCM physician, helps Microsoft adopt tech and AI tools, and Woo, a rail engineer, manages generative AI projects at PwC.

  9 min read
• Anthropic's IPO prospectus: H1 2026 revenue of $16.3B, ~20% from two customers, vs. $1.1B in H1 2025, and an $80.7B net loss driven by accounting charges (Anissa Gardizy/Wall Street Journal)

  Anthropic, an AI company, has disclosed a significant financial performance in its first half of 2026, reporting $16.3 billion in revenue, with 20% coming from two key customers. This represents a substantial increase from $1.1 billion in 2025, while the net loss of $80.7 billion is notably higher, driven by accounting charges. The prospectus highlights various risk factors, including regulatory challenges and potential declines in AI adoption.

  1 min read
• Boeing wins FAA approval for 737 Max 10 after years of delays

  The Federal Aviation Administration has approved the Boeing 737 Max 10, a key model in the manufacturer's best-selling family of jets, after years of delays. This approval follows a thorough review of the aircraft's design and safety requirements, and is expected to boost orders and production efforts for the company.

  1 min read